Measuring glucose in vivo over the long term is challenging and difficult. Previous measurement systems were limited to acute studies or a few days at best. WPI introduces a new kind of implantable glucose sensor based on a patented technology. This sensor provides a tool for researchers to directly detect glucose in chronic studies in vitro or in vivo. The sensor is fully compatible with WPI’s Apollo system.